A Study for Expanding Application Sites for Rotigotine Transdermal Patch

The rotigotine transdermal patch (RTP) is a dopamine agonist used to treat Parkinson's disease (PD). Some PD patients cannot continue RTP treatment due to application site reactions. We explored sites for RTP where application site reactions are less severe than those in the six approved applic...

Full description

Saved in:
Bibliographic Details
Published in:Parkinsons Dis
Main Authors: Kujirai, Hitoshi, Itaya, Sakiko, Ono, Yumi, Takahashi, Makoto, Inaba, Akira, Shimo, Yasushi, Hattori, Nobutaka, Orimo, Satoshi
Format: Artigo
Language:Inglês
Published: Hindawi 2020
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7436353/
https://ncbi.nlm.nih.gov/pubmed/32850112
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/5892163
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items